Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07816718) titled 'Sustained Asthma Remission and Reduced RElapse Using a COmprehensive Management Strategy Randomized Control Trial' on Sept. 8.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
Primary Sponsor: Hana Serajeddini
Condition:
Asthma (Diagnosis)
Intervention:
Other: Comprehensive Biomarker-Guided Management Strategy
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: December 2, 2026
Target Sample Size: 50
Countries of Recruitment:
Canada
To know more, visit https://clinic...